DAMICO JENNIFER B.
SEC CIK 1805617 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | SVP, Ctrl | 28.6K | — | $1.36M | 36 | 2021-07-30 | 2026-08-05 |
Most active insiders at PFE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOURLA ALBERT | COB, CEO, Dir | $1.00M | — |
| 2 | BLAYLOCK RONALD E | Dir | $998.8K | — |
| 3 | Buckley Mortimer J | Dir | $960.4K | — |
| 4 | DAMICO JENNIFER B. | SVP, Ctrl | — | $134.7K |
| 5 | BOSHOFF CHRISTOFFEL | Pres, R, D | — | — |
| 6 | McDermott Michael | EVP | — | — |
| 7 | SAHNI PAYAL | EVP | — | — |
| 8 | LANKLER DOUGLAS M | EVP | — | — |
| 9 | Fonseca Lidia | EVP | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 11:26 | 2026-08-05 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $25.40 | -3,278 | 28.6K | -10% | -$83.3K | |
| 2026-06-10 19:58 | 2026-06-09 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $25.70 | -2,000 | 31.4K | -6% | -$51.4K | |
| D | 2026-03-05 | 2026-03-04 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $26.62 | -826 | 32.9K | -2% | -$22.0K |
| DM | 2026-03-05 | 2026-03-03 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +21.7K | 33.8K | +180% | $0 |
| 2026-03-03 | 2026-02-27 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $27.65 | -655 | 12.0K | -5% | -$18.1K | |
| D | 2026-02-27 | 2026-02-25 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $33.82 | +17.6K | 29.7K | +144% | +$593.8K |
| DM | 2026-02-27 | 2026-02-25 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $26.92 | -17.0K | 29.4K | -37% | -$459.0K |
| 2026-02-24 | 2026-02-23 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $27.06 | -419 | 12.2K | -3% | -$11.3K | |
| D | 2025-03-06 | 2025-02-27 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $26.10 | -749 | 29.8K | -2% | -$19.5K |
| D | 2025-03-06 | 2025-03-04 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +5,583 | 14.3K | +64% | $0 |
| D | 2025-03-06 | 2025-03-04 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $25.93 | -2,500 | 11.8K | -17% | -$64.8K |
| A | 2025-03-03 | 2025-02-24 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $26.65 | -377 | 8,647 | -4% | -$10.0K |
| DM | 2025-03-03 | 2025-02-27 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $26.06 | -21.5K | 9,516 | -69% | -$561.5K |
| D | 2025-03-03 | 2025-02-27 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $31.31 | +22.4K | 31.1K | +259% | +$701.8K |
| DM | 2025-02-25 | 2025-02-22+ | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $26.10 | -8,578 | 9,414 | -48% | -$223.9K |
| D | 2025-02-25 | 2025-02-22 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $30.17 | +8,741 | 17.6K | +99% | +$263.7K |
| 2024-08-14 | 2024-08-13 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $28.66 | -5,154 | 8,582 | -38% | -$147.7K | |
| D | 2024-02-28 | 2024-02-27 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +5,113 | 13.5K | +61% | $0 |
| DM | 2024-02-27 | 2024-02-23+ | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $27.48 | -10.8K | 18.8K | -37% | -$298.0K |
| D | 2024-02-27 | 2024-02-23 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $27.34 | +9,752 | 19.2K | +103% | +$266.6K |
| D | 2023-03-17 | 2023-03-15 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $40.02 | -9,912 | 9,003 | -52% | -$396.7K |
| D | 2023-03-17 | 2023-02-24 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $41.75 | -360 | 16.4K | -2% | -$15.0K |
| DM | 2023-02-28 | 2023-02-25+ | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $42.56 | -8,618 | 25.7K | -25% | -$366.8K |
| D | 2023-02-28 | 2023-02-25 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $22.89 | +11.2K | 27.9K | +67% | +$255.2K |
| DM | 2023-02-24 | 2023-02-22 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $43.44 | -7,944 | 13.6K | -37% | -$345.1K |
| D | 2023-02-24 | 2023-02-22 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $30.17 | +10.5K | 21.6K | +94% | +$315.5K |
| D | 2023-02-24 | 2023-02-23 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +3,103 | 16.7K | +23% | $0 |
| 2022-06-08 | 2022-06-07 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $53.96 | -4,218 | 10.8K | -28% | -$227.6K | |
| D | 2022-05-17 | 2022-05-16 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $50.50 | -4,000 | 15.1K | -21% | -$202.0K |
| DM | 2022-03-01 | 2022-02-26+ | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $49.49 | -7,142 | 24.3K | -23% | -$353.5K |
| D | 2022-03-01 | 2022-02-26 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $25.60 | +9,713 | 26.1K | +59% | +$248.7K |
| D | 2022-02-25 | 2022-02-23 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | M - OptEx | $27.34 | +11.7K | 21.7K | +118% | +$321.2K |
| D | 2022-02-25 | 2022-02-24 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $0.00 | +2,893 | 16.4K | +21% | $0 |
| DM | 2022-02-25 | 2022-02-23 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $50.01 | -8,154 | 13.5K | -38% | -$407.8K |
| DM | 2021-08-16 | 2021-08-13 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $48.30 | -1,661 | 11.4K | -13% | -$80.2K |
| D | 2021-08-02 | 2021-07-30 | PFE | Pfizer | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $42.86 | -2,500 | 11.4K | -18% | -$107.2K |
Purchase Sale Sale after option exercise All abbreviations